Information  X 
Enter a valid email address

Citigroup GM Fdg Lux (IRSH)

  Print      Mail a friend

Friday 12 July, 2019

Citigroup GM Fdg Lux

Article 8

RNS Number : 4120F
Citigroup Global Markets Fdg Lux
12 July 2019
 

Execution Version

NOTICE

pursuant to the Final Terms dated 14 May 2019, as amended and restated by the Amended and Restated Final Terms dated 30 May 2019 and the Amended and Restated Final Terms dated 10 July 2019 (the Final Terms)

relating to

Citigroup Global Markets Funding Luxembourg S.C.A.

Issue of up to GBP 5,000,000 Citigroup Global Markets Funding Luxembourg S.C.A. Notes due July 2029 linked to the Worst Performing of the FTSE 100® Index and the S&P 500® Index

 

Guaranteed by Citigroup Global Markets Limited

Under the Citi U.S.$60,000,000,000 Global Medium Term Note Programme

 

(Series Number: CGMFL7181, ISIN: XS1980011800)

 

The Issuer hereby provides notice in accordance with the Final Terms that:

(a)        the final Aggregate Principal Amount of the Notes to be issued on 12 July 2019 will be GBP 2,120,000;

(b)        the title of the Notes is now "Issue of GBP 2,120,000 Citigroup Global Markets Funding Luxembourg S.C.A. Notes due July 2029 linked to the Worst Performing of the FTSE 100® Index and the S&P 500® Index"; and

(c)        the final distribution fee payable to the Authorised Offeror in respect of the Notes to be issued on 12 July 2019 will be 0.90 per cent. of the Aggregate Principal Amount.

 

Capitalised terms used but not defined herein shall be as defined in the Final Terms.

 

This Notice and the Final Terms shall be read and construed together as one document.

 

 

 

 

 

 

 

 

This announcement has been issued through the Companies Announcement Service of Euronext Dublin.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEEAFXAFLPNEFF

a d v e r t i s e m e n t